Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 1/20 | 0.65 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.57 |
| ▸ | CTSL | P07711 | 2/20 | 0.55 |
| ▸ | CTSS | P25774 | 2/20 | 0.55 |
| ▸ | CTSK | P43235 | 2/20 | 0.55 |
| ▸ | CTSH | P09668 | 1/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.55 |
| ▸ | APLNR | P35414 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31733948 | 0.98 | GNRHR (0.67) | GNRHRABCC2PTGS1C5AR1APLNR | |
| SCHEMBL29857994 | 0.98 | GNRHR (0.67) | GNRHRABCC2PTGS1C5AR1APLNR | |
| SCHEMBL11315269 | 0.95 | GNRHR (0.71) | GNRHRABCC2PTGS1C5AR1CTSL | |
| SCHEMBL29425251 | 0.95 | GNRHR (0.64) | GNRHRABCC2PTGS1C5AR1CXCR4 | |
| SCHEMBL29858408 | 0.95 | PTGS1 (0.65) | GNRHRABCC2PTGS1C5AR1CTSL | |
| SCHEMBL30839204 | 0.95 | GNRHR (0.64) | GNRHRABCC2PTGS1C5AR1CXCR4 | |
| SCHEMBL29373920 | 0.95 | PTGS1 (0.72) | GNRHRABCC2PTGS1C5AR1CTSL | |
| SCHEMBL29857989 | 0.95 | GNRHR (0.63) | GNRHRABCC2PTGS1C5AR1APLNR | |
| SCHEMBL29390323 | 0.94 | ABCC2 (0.63) | GNRHRABCC2PTGS1C5AR1APLNR | |
| Deslorelin SCHEMBL25353366 | 0.94 | GNRHR (0.74) | GNRHRABCC2PTGS1C5AR1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111789936-B | Alarelin composition and preparation method thereof | 深圳市星银医药有限公司 | 2023-09-15 | — | — | CN | disclosed |